bs 2513r (Bioss)
Bioss is a verified supplier 
Bioss manufactures this product 
94
Structured Review
Bioss
bs 2513r
Bs 2513r, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 37 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bs+2513r/NFKBIA(Ser32+36)+Polyclonal+Antibody/pmc12945281-12-2-4
Average 94 stars, based on 37 article reviews
Bs 2513r, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 37 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bs+2513r/NFKBIA(Ser32+36)+Polyclonal+Antibody/pmc12945281-12-2-4
Average 94 stars, based on 37 article reviews
bs 2513r - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Western Blot:Article Title: Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction. Article Snippet: Biglycan (BGN) is overexpressed in cancer stem cells of colon cancer and induces the activation of NF-κB pathway which contributes to the chemotherapy resistance of diverse cancer types.. Therefore, we hypothesized that the overexpression of BGN also promoted the development of multiple drug resistance (MDR) in colon cancer via NF-κB pathway.. The expression of BGN was bilaterally modulated in colon cancer cell lines HT-29 and SW-480 and the effect of treatments on the cell proliferation and resistance to 5-FU was assessed. Polyacrylamide Gel Electrophoresis:Article Title: Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction. Article Snippet: Biglycan (BGN) is overexpressed in cancer stem cells of colon cancer and induces the activation of NF-κB pathway which contributes to the chemotherapy resistance of diverse cancer types.. Therefore, we hypothesized that the overexpression of BGN also promoted the development of multiple drug resistance (MDR) in colon cancer via NF-κB pathway.. The expression of BGN was bilaterally modulated in colon cancer cell lines HT-29 and SW-480 and the effect of treatments on the cell proliferation and resistance to 5-FU was assessed. Incubation:Article Title: Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction. Article Snippet: Biglycan (BGN) is overexpressed in cancer stem cells of colon cancer and induces the activation of NF-κB pathway which contributes to the chemotherapy resistance of diverse cancer types.. Therefore, we hypothesized that the overexpression of BGN also promoted the development of multiple drug resistance (MDR) in colon cancer via NF-κB pathway.. The expression of BGN was bilaterally modulated in colon cancer cell lines HT-29 and SW-480 and the effect of treatments on the cell proliferation and resistance to 5-FU was assessed. other:Article Title: Protective Effects of Chitosan Oligosaccharide Against Lipopolysaccharide-Induced Inflammatory Response and Oxidative Stress in Bovine Mammary Epithelial Cells Article Snippet: p-IκBα , Article Title: Knockout of the C4BPA Gene Promotes Mitophagy via Activation of the Pink1/Parkin Pathway and Alleviates the Inflammatory Response by Inhibiting the NF-κB Signalling Pathway in Bovine Mammary Epithelial Cells Article Snippet: P-IκBα , |
